Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies. - Wikidata - awgldk - TriplyDB

Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

http://www.wikidata.org/entity/Q35909637

about

FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-κB to promote survival of human B cells Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple Myeloma The role of aberrant proteolysis in lymphomagenesis Tax-1 and Tax-2 similarities and differences: focus on post-translational modifications and NF-κB activation.Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers.Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy.MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer.Genetic methylation and lymphoid malignancies: biomarkers of tumor progression and targeted therapy.GFI1 is repressed by p53 and inhibits DNA damage-induced apoptosis.RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53abnormal myeloma cells independently of the p53 pathway.TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases.The mechanism of Jurkat cells apoptosis induced by Aggregatibacter actinomycetemcomitans cytolethal distending toxin.TP53 mutation predicts the poor prognosis of non-Hodgkin lymphomas: Evidence from a meta-analysis.Antiangiogenic effects of oridonin.Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study The spectrum of genetic defects in chronic lymphocytic leukemia.Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans.The mTORC1 inhibitor everolimus prevents and treats Eμ-Myc lymphoma by restoring oncogene-induced senescence.Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells miR-31 and miR-17-5p levels change during transformation of follicular lymphoma Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia.TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.Yes-associated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53.TP53 Gene Status Affects Survival in Advanced Mycosis Fungoides.MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.Mutations or copy number losses of CD58 and TP53 genes in diffuse large B cell lymphoma are independent unfavorable prognostic factors.Diagnostic techniques and therapeutic challenges in patients with TP53 dysfunctional chronic lymphocytic leukemia.Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?Regulation of miRNA biogenesis and turnover in the immune system.TP53 mutations in human cancer: database reassessment and prospects for the next decade.Screening Feature Genes of Venous Thromboembolism with DNA Microarray.To Each Its Own: Linking the Biology and Epidemiology of NHL Subtypes.Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine.Ellipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage.P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma.Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.CD30 expression and its correlation with MYC rearrangement in de novo diffuse large B-cell lymphoma.The p53 Mutation/Deletion Profile in a Small Cohort of the Omani Population with Diffuse Large B-Cell Lymphoma.

P2860

Q24304887-C044D299-F593-407A-A30B-DFED52E7D8A3 Q27304386-319BAB3C-B8D4-4DD5-90DE-C97C245E4943 Q28074490-322387AF-C224-4F8C-9ADB-F0D506008D49 Q28084404-9608F0BA-729B-4740-875F-0502F98D2D38 Q30353061-A3ED053C-37C3-410A-ADB9-A2DF756B7D7D Q33755493-697D61EF-3177-480A-8EEE-FE95227B6AC2 Q33846801-4622382F-79FF-4F66-995C-D323BA1DD32B Q33869257-F428D14E-8A7A-4E2E-BA19-6EF6A37DB662 Q33913937-2B022F48-3ED8-4DCD-B4E3-DA42400F4BD4 Q34984471-B1C84CA8-65F9-49E7-B6DD-6F5B2D7E7B92 Q35187880-D865EDFC-21C0-4323-A686-C2599F825D99 Q35606212-45A4809F-8A9F-4D5B-A072-B8FA7CC04ADA Q36293421-1C04BDC9-8089-45E2-9420-C4180A23F20E Q36332053-4CE54359-C7A5-46CC-9273-92FB59CC301F Q36334914-AAA3AF66-ABDE-46E4-BC11-C79EA015C2C8 Q36395599-71D85FED-B74C-4644-AF59-8F6BE3A7D557 Q36426587-E38DF16C-D265-4DEC-A47A-9139B634E5DC Q36494000-6A22186B-1827-45CA-AA73-E0834AF12FA6 Q36509629-70E3E03F-83FD-4439-A363-C9E52924BA65 Q36541067-3197C9C0-6EC5-4045-98FB-390102FC60F0 Q36651351-3A1FD759-3E52-4C8A-A596-AC0D05F1577B Q36719087-63039896-B9DA-4EA9-B9C8-107D90FE21B7 Q36734163-3B6C4C01-C634-4C77-B2BD-36FF1D715230 Q36825602-969012E0-29A9-45FD-8580-789515E36790 Q37269206-C5E740A2-2C9F-4A88-8338-B040BAEE3967 Q37407941-8B5B4375-995D-44E0-8189-7D24D1DE1832 Q37635027-D2BEAC8C-94E5-46CA-B738-2FF8743D53E0 Q37696308-47168F3C-D380-4A74-BDE4-593EB0D64710 Q38008448-4DE18077-6287-4F25-AC0A-110C46CBA906 Q38088354-8E240ECD-9FF5-40AF-9374-137BFD9BE445 Q38095509-0E27F3CE-A16F-4FA4-844A-756EFB6CA6C9 Q38199075-6F9E0991-1F10-47CF-B1DB-9AB191E961D7 Q38300411-5635C417-DC41-4681-BEAC-9712D7DCE8AC Q38536210-64469196-6086-4350-9B6C-85B70D88A096 Q38882112-B2AF30E7-7058-4130-BCAA-61E3C97DF7AE Q38988248-AC72FE65-FB3F-4F45-84F4-8F69EA7ABA69 Q39292664-120AC2CB-5907-4C76-B54C-BF11D8C051A1 Q39406673-6F367FCA-7248-41CD-A83F-C02A562EEEA1 Q41411254-66A17362-DA71-4765-8233-4F20AD27F492 Q41891965-4507BC71-FEF7-48AA-B828-BA22F8369052

P2860

Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

http://www.wikidata.org/entity/Q35909637

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

@ast

Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

@en

type

label

Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

@ast

Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

@en

prefLabel

Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

@ast

Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

@en

P1433

Q35909637-61D13061-352D-48C6-894D-5B06B1D450F9

P1476

Q35909637-1C051DD8-90A8-4837-8F0F-18265262C270

P2093

Q35909637-369DD66A-EEF0-4277-80D0-F2AE1B405790

Q35909637-3797B719-4E2F-42CB-AE74-20C74CA3E87C

Q35909637-3D826A3D-EBB3-4AD6-8AFA-3DEFB9BA50DD

Q35909637-66B9F2D4-DBC4-4B0D-8860-20D60BD08E61

Q35909637-8F26F4A8-84DF-4D4F-9C1D-B27FDF6C24BC

Q35909637-EB0F6B1D-12A3-448B-BAEB-54D48A29D535

Q35909637-EF4AA37A-94EB-4B34-8574-0D4CE0086263

P2860

Q35909637-00201C9F-0A6E-4E1F-82D5-792DA3D03EB6

Q35909637-02FCEFE7-D67C-41AA-A1D8-F7108322D778

Q35909637-07D5F04F-0474-4951-8F64-F38948CAA684

Q35909637-084EF249-263C-44E2-8F8A-42031CC4393A

Q35909637-093982EC-4265-4F87-A8CA-D50C0707E0F0

Q35909637-09F06A02-86E3-48FB-B9EE-171C9A1C5E44

Q35909637-0A607D79-27DD-4E29-900D-8665FAFBD0F6

Q35909637-0A809E4B-EFE3-4534-B751-A42FD1E51462

Q35909637-0A8A480D-33A3-42CB-95E0-EB2E97DA55B2

Q35909637-0D3DA64D-AAE0-43EA-AC13-469BCDD9BA20

P304

Q35909637-081B8313-5AA4-44BA-BFC7-A428C3BDDF0B

P31

Q35909637-EFF8E1A5-2995-464B-91D1-08D56CCA464D

P356

Q35909637-D36A4477-86CF-487E-80D7-E6095450AE8F

P407

Q35909637-B7703CC1-9DEC-446F-9F21-C15FB22BDEB7

P433

Q35909637-89880669-DDCF-4E28-8943-6D7B55C09877

P478

Q35909637-C64D365B-2272-4A01-8D7F-CE0D364EFA99

P50

Q35909637-0B1324C6-306D-456C-A7FD-5CAF712839E7

Q35909637-FD21ACDC-7650-45C4-9A49-E2D9E36DB938

P577

Q35909637-5FBB822C-F27D-410E-9F6F-64B2D19A2C78

P5875

Q35909637-409CB5BA-0B32-44B8-9B29-E7EDA0C2E6D4

P698

Q35909637-D252E830-5647-404A-A83E-2220836E0078

P932

Q35909637-1D587CCA-4141-40DE-B340-61202D83861D

P356

BLOOD-2011-11-366062

P1433

P1476

Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

@en

P2093

Carlos E Bueso-Ramos

http://www.w3.org/2001/XMLSchema#string

Ken H Young

http://www.w3.org/2001/XMLSchema#string

L Jeffrey Medeiros

http://www.w3.org/2001/XMLSchema#string

Timothy C Greiner

http://www.w3.org/2001/XMLSchema#string

Timothy J McDonnell

http://www.w3.org/2001/XMLSchema#string

Yong Li

http://www.w3.org/2001/XMLSchema#string

Zijun Y Xu-Monette

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of human p53 activity and cell localization by alternative splicing

p53 isoforms can regulate p53 transcriptional activity.

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

MicroRNAs: target recognition and regulatory functions

Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development

Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein

Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells

A microRNA polycistron as a potential human oncogene

P304

3668-3683

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2011-11-366062

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Michael Andreeff

Robert Z Orlowski

P577

2012-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221775605

http://www.w3.org/2001/XMLSchema#string

P698

22275381

http://www.w3.org/2001/XMLSchema#string

P932

3335376

http://www.w3.org/2001/XMLSchema#string